Skip to main content
AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
208.45
+4.47 (2.19%)
At close: Feb 27, 2026, 4:00 PM EST
207.51
-0.94 (-0.45%)
After-hours: Feb 27, 2026, 7:34 PM EST

AstraZeneca Revenue

In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth. AstraZeneca had revenue of $15.50B in the quarter ending December 31, 2025, with 4.11% growth.

Revenue (ttm)
$58.74B
Revenue Growth
+8.63%
P/S Ratio
5.52
Revenue / Employee
$617,655
Employees
95,100
Market Cap
324.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 94.19B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
Novartis AG 56.67B
Sanofi 54.85B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

AZN News

More News